Health Care Up on Rotation Into Laggards -- Health Care Roundup

Dow Jones06-24 06:25

Health-care companies rose as traders rotated into lagging sectors from the high-flying tech industry group.

French drug giant Sanofi received European Union approval for a new medicine for multiple sclerosis, months after it was turned down by U.S. drug regulators.

Federal health officials unveiled a package of regulatory reforms on Monday with the aim of cutting about six months to a year off the time it takes to do a safety study in the U.S., amid concerns about the increase in off-shoring pharmaceutical research and development.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

June 23, 2026 18:25 ET (22:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment